Cell Source Inc logo

Cell Source Inc

$ 0.00 0 (0%) 11:08 AM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 83.00K
Enterprise V:
$ 6.46M
Volume:
-
Avg Vol (2M):
3.12K
Volume:
-
Market Cap $:
83.00K
PE Ratio:
At Loss
Avg Vol (2-Month):
3.12K
Enterprise Value $:
6.46M
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Cell Source Inc is a biotechnology company focused on developing cell therapy treatments focused on immunotherapy. The company's subsidiary commercializes a suite of inventions relating to certain cancer treatments. Its other products include Anti-rejection Veto Cell tolerance therapy for both matched and mismatched allogeneic bone marrow transplantations and Anti-rejection Veto Cell tolerance therapy for both matched and mismatched organ transplantation.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.01
Equity-to-Asset -31.29
Debt-to-Equity -0.66
Debt-to-EBITDA -1.57
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 14.08
9-Day RSI 25
14-Day RSI 28.97
6-1 Month Momentum % -99.65
12-1 Month Momentum % -99.82

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.03
Quick Ratio 0.03
Cash Ratio 0.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.6

Profitability Rank

Name Current Vs Industry Vs History
ROA % -1213.53
ROIC % -58.14

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -1.57
EV-to-EBITDA -1.57
EV-to-FCF -1.91
Earnings Yield (Greenblatt) % -63.69

Financials

CLCS's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:CLCS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.19
Beta 1.72
Volatility % 112.11
14-Day RSI 28.97
14-Day ATR ($) 0.038042
20-Day SMA ($) 0.18144
12-1 Month Momentum % -99.82
52-Week Range ($) 0.0024 - 1.89
Shares Outstanding (Mil) 34.44

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cell Source Inc Filings

Document Form Filing Date
No Filing Data

Cell Source Inc Analysis

Share your research

Headlines

See More
No news.